PhaseV has secured $50 million in Series A funding to [...]
Vesper Bio has reached a key enrolment milestone in its [...]
DFE Pharma has achieved ISO 22301 certification for Business Continuity [...]
Elsevier has announced the addition of over 500,000 clinical trial [...]
Research from Bayes Business School and Merck KGaA identifies barriers [...]